Boston Scientific (BSX) Raises Share Buyback Authorization To $5B

Boston Scientific Corp. (NYSE:BSX) is one of the 15 best stocks to invest in according to billionaires.

On February 24, Boston Scientific Corp. (NYSE:BSX) increased its share buyback authorization to $5 billion. In a regulatory filing, the company stated:

On February 18, 2026, the Board approved an increase to the company’s existing authorization to repurchase up to $1.0 billion of the company’s common stock by an additional $4.0 billion. As a result, the company is authorized to repurchase up to a total of $5.0 billion of common stock under the company’s stock repurchase program, all of which remains available as of the date hereof.

On February 17, William Plovanic from Canaccord Genuity reduced the price target on Boston Scientific Corp. (NYSE:BSX) to $109 from $112. The analyst reaffirmed his Buy rating on the stock, which still offers an upside potential of almost 42% despite the downward revision.

Plovanic’s rating is based on the firm’s revision to its model and projections to reflect the business’s organizational restructuring. Plovanic also adjusted his estimates based on management’s remarks during the earnings call and the subsequent commentary.

Boston Scientific Corp. (NYSE:BSX) specializes in medical devices for interventional specialties such as cardiovascular, endo-surgery, and neuro-modulation. The company operates through the MedSurg and Cardiovascular segments and offers a range of devices, including biliary stent systems, electrocautery-enhanced delivery systems, direct visualization systems, and single-use duodenoscopes.

While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT:40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest in According to Hedge Funds.

Disclosure: None. Follow Insider Monkey on Google News.